Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of AZD1656 in Type 2 Diabetes Patients on Metformin
NCT00817778Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD1656 in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Jan 2009; status: completed.
02
Drugs
AZD1656
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00817778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817778.